About Us
CRISPRomics®
+
CRISPRomics®
Publications
Pipeline
+
Pipeline®
Expanded Access Policy
News
People
+
Leadership Team
Board of Directors
Careers
Contact
Follow us on Twitter
Find us on LinkedIn
KSQ-001EX, an Engineered TIL Therapy, Manufactured from a Clinical-Scale, Feeder-Free Process for the Treatment of Solid Tumor Indications
April 7, 2024
“KSQ-001EX, an Engineered TIL Therapy, Manufactured from a Clinical-Scale, Feeder-Free Process for the Treatment of Solid Tumor Indications”
© 2024 KSQ Therapeutics, Inc. All rights reserved.